三生制药(01530.HK)首席财务官均价5.99元增持300万股

阿斯达克财经
15 Nov 2024

三生制药(01530.HK) 公布,首席财务官何翔自今年1月1日起至今,通过集中竞价方式计增持300万股,占公司股本0.12%,每股平均价5.99元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-14 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10